Annual respiratory syncytial virus-associated hospitalization rates varied from 35.7 to 132.3 per 1000 children aged younger than 6 months.
Your search for supplemental oxygen returned 21 results
Gohibic is supplied as a 200mg/20mL solution in a single-dose vial for IV infusion after dilution.
Overview On March 11, 2020, the World Health Organization (WHO) declared a global pandemic of a novel respiratory coronavirus, now known as SARS-CoV-2.1 Rapid spread of the original virus and its multiple variants led to more than 1 million deaths in the United States and nearly 7 million deaths worldwide by the time the WHO…
Researchers examined the epidemiology and clinical outcomes of sporadic health care-associated respiratory syncytial virus infection in children.
Odds of mortality or discharge to hospice reduced for those receiving supplemental oxygen or mechanical ventilation and/or ECMO
InflaRx is working to increase supply of the product in the US as quickly as possible.
Significant reductions seen in RSV-related infections, RSV-related hospitalizations for three monoclonal antibodies versus placebo
Methods to prevent and treat COVID-19 in cancer patients have had to evolve alongside the SARS-CoV-2 virus.
The studies evaluated routine clinical practice data from more than 800 hospitals in the US.
While naloxone, a short-acting opioid antagonist, has become the standard treatment for opioid overdose, there are situations where longer-acting opioid antagonists are a more appropriate treatment choice, especially considering the rise of fentanyl. In this article, Dr Adam Bisaga, professor of psychiatry at the Columbia University Irving Medical Center in New York and research scientist at the New York State Psychiatric Institute, discusses various clinical considerations in the treatment of opioid overdose and opioid use disorder.